Gene Therapy for Rare Disorders Europe brings together leaders in the gene therapy field to discuss critical factors involved in driving commercial success for gene therapies in the complex European landscape. Patricia Hurley, Senior Director, PPD, and Matthew Bending, Executive Director of HTA Strategy, Evidera, will be presenting a session titled, Integrated Scientific Advice to Support Optimized Evidence Development And Obtain Timely Patient Access For Gene Therapies.
